Fig. 6: Susceptibility of RSV B strains with and without prevalent nirsevimab binding site substitutions I206M + Q209R.
F, fusion protein; IC50 half-maximal inhibitory concentration, LOD limit of detection, RSV respiratory syncytial virus.
Fig. 6: Susceptibility of RSV B strains with and without prevalent nirsevimab binding site substitutions I206M + Q209R. | Nature Communications
